Compare UPC & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPC | UCL |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.6M |
| IPO Year | 2020 | 2019 |
| Metric | UPC | UCL |
|---|---|---|
| Price | $1.47 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 142.8K | ★ 194.7K |
| Earning Date | 01-29-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.99 |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $0.20 |
| 52 Week High | $17.96 | $2.63 |
| Indicator | UPC | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 22.26 | 22.54 |
| Support Level | N/A | N/A |
| Resistance Level | $3.39 | $0.44 |
| Average True Range (ATR) | 0.52 | 0.02 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 0.00 | 12.63 |
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.